Tests find banned substance in Tallinn CBD joint
Thursday 19th November 2026 on 07:15 in
Estonia
A cannabis-like product sold at a shop in Tallinn’s Old Town contained a prohibited psychoactive substance, according to tests reported by ERR. The product was linked to unusual and prolonged health complaints among dozens of people this autumn.
The Estonian Forensic Science Institute found that a joint containing CBD had 11 percent CBD and 0.32 percent THC. It also contained a semisynthetic cannabinoid, a new psychoactive substance whose effects and health risks are not yet well understood, the National Institute for Health Development said.
Semisynthetic cannabinoids have been on Estonia’s list of narcotic and psychotropic substances since August 2026. The product, sold freely as a legal CBD product, therefore contained a controlled substance and could not lawfully be marketed. The institute’s drug policy lead, Katri Abel-Ollo, also said the THC level may have exceeded the permitted limit, taking the margin of error into account.
Police have opened proceedings to establish how the products reached the Estonian market and who was responsible for distributing them. Artur Kamnerov, head of the Northern Prefecture’s narcotics and organised crime unit, said the case showed that the actual contents and effects of cannabis-like products may be unknown to both sellers and consumers.
Between August 21 and September 21, 2026, the Poison Information Centre recorded at least 10 to 12 linked cases involving health complaints from 26 people. The accounts all mentioned buying a cannabis-like product at CBD Italy, a shop in Tallinn’s Old Town. The product was referred to as CBCX60% and as a joint from the Old Town CBD shop.
One person went to an emergency department after experiencing aggression, hallucinations, a seizure, involuntary urination and prolonged confusion after smoking the product. Reported symptoms also included paranoia, impaired consciousness, delirium-like episodes, vomiting, severe tremors, a racing heart and high blood pressure. In some cases, impaired consciousness lasted more than 36 hours; other complaints persisted for days or weeks.